Literature DB >> 15068807

Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine.

Mark J Hickman1, Leona D Samson.   

Abstract

Until now, it has been difficult to establish exactly how a specific DNA lesion signals apoptosis because each DNA damaging agent produces a collection of distinct DNA lesions and produces damage in RNA, protein, and lipids. We have developed a system in human cells that focuses on the response to a single type of DNA lesion, namely O(6)-methylguanine (O(6)MeG). We dissect the signaling pathways involved in O(6)MeG-induced apoptosis, a response dependent on the MutSalpha heterodimer that is normally involved in DNA mismatch repair. O(6)MeG triggers robust activation of caspases associated with both death receptor- and mitochondrial-mediated apoptosis. Despite this, O(6)MeG/MutSalpha-triggered apoptosis is only partly dependent on caspase activation; moreover, it is mediated solely by mitochondrial signaling and not at all by death receptor signaling. Finally, while Bcl-2 and Bcl-x(L), negative regulators of mitochondrial-regulated apoptosis, could effectively block O(6)MeG/MutSalpha-dependent apoptosis, they were unable to prevent the cells from ultimately dying.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068807     DOI: 10.1016/s1097-2765(04)00162-5

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  40 in total

1.  Mismatch repair causes the dynamic release of an essential DNA polymerase from the replication fork.

Authors:  Andrew D Klocko; Jeremy W Schroeder; Brian W Walsh; Justin S Lenhart; Margery L Evans; Lyle A Simmons
Journal:  Mol Microbiol       Date:  2011-09-30       Impact factor: 3.501

2.  Phosphorylated hMSH6: DNA mismatch versus DNA damage recognition.

Authors:  Saravanan Kaliyaperumal; Steve M Patrick; Kandace J Williams
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

3.  Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.

Authors:  Elizabeth Peterson-Roth; Mindy Reynolds; George Quievryn; Anatoly Zhitkovich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 4.  MGMT: a personal perspective.

Authors:  Sankar Mitra
Journal:  DNA Repair (Amst)       Date:  2007-05-07

5.  Prolonged cell cycle response of HeLa cells to low-level alkylation exposure.

Authors:  Allen G Schroering; Anbarasi Kothandapani; Steve M Patrick; Saravanan Kaliyaperumal; Vishal P Sharma; Kandace J Williams
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

6.  Genomic predictors of interindividual differences in response to DNA damaging agents.

Authors:  Rebecca C Fry; J Peter Svensson; Chandni Valiathan; Emma Wang; Brad J Hogan; Sanchita Bhattacharya; James M Bugni; Charles A Whittaker; Leona D Samson
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

7.  Single-molecule FRET TACKLE reveals highly dynamic mismatched DNA-MutS complexes.

Authors:  Lauryn E Sass; Cherie Lanyi; Keith Weninger; Dorothy A Erie
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

8.  Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.

Authors:  Haiyan Wang; Shanbao Cai; Aaron Ernstberger; Barbara J Bailey; Michael Z Wang; Wenjing Cai; W Scott Goebel; Magdalena B Czader; Colin Crean; Attaya Suvannasankha; Inna Shokolenkoc; Glenn L Wilson; Arthur R Baluyut; Lindsey D Mayo; Karen E Pollok
Journal:  Clin Cancer Res       Date:  2013-03-27       Impact factor: 12.531

9.  Beta clamp directs localization of mismatch repair in Bacillus subtilis.

Authors:  Lyle A Simmons; Bryan W Davies; Alan D Grossman; Graham C Walker
Journal:  Mol Cell       Date:  2008-02-15       Impact factor: 17.970

10.  MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

Authors:  J R McDaid; J Loughery; P Dunne; J C Boyer; C S Downes; R A Farber; C P Walsh
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.